23.7 C
June 26, 2022

Antibiotice Iasi profit 12.5 pc higher last year

Pharmaceutical company Antibiotice Iasi recorded a 12.5 per cent increase in profit last year compared to 2012, to RON 28.8 million (EUR 6.5 million) and a 4.4 per cent increase in their sales, to RON 317.4 million (EUR 71.8 million), according to provisional results of the company sent to Bucharest Stock Exchange (BVB). In 2012, the company reported a RON 25.6 million profit and sales revenues in amount of RON 304 million. According to previous information sent to BVB, the company’s exports reached USD 26.9 million, 34 per cent higher compared to 2012, and the company’s forecast for this year aim an increase higher than 10 per cent, as they will cover new markets. The major foreign markets of Antibiotice company are the US, North Africa, Europe, Russia and the Middle East, and this year the company aims to join markets in the European Union and Australia.

Related posts

€350.000 is the record investment prize value offered to the best startup at the end of the Spotlight 2021 program


EC contradicts minister Sova regarding Pitesti – Sibiu highway

Nine O' Clock

Romania’s chemical industry – a strong economic recovery driver

Nine O' Clock